Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Tyvaso DPI1.03B35.92%
Nebulized Tyvaso586.8M20.39%
Remodulin538.1M18.70%
Orenitram434.3M15.09%
Unituxin238.7M8.30%
Adcirca23.8M0.83%
Other22.1M0.77%
View all
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States2.74B95.21%
Rest-of-World (ROW)137.7M4.79%